ELITE.E — Elite Naturel Organik Gida Sanayi ve Ticaret AS Balance Sheet
0.000.00%
- TRY3.74bn
- TRY3.71bn
- TRY2.15bn
Annual balance sheet for Elite Naturel Organik Gida Sanayi ve Ticaret AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
R2021 December 31st | R2022 December 31st | R2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Interim Report | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 94.2 | 33.5 | 46.4 | 118 | 186 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 192 | 421 | 654 | 913 | 749 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 370 | 750 | 1,144 | 1,672 | 1,530 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 63.7 | 374 | 605 | 921 | 935 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 435 | 1,136 | 1,774 | 2,628 | 2,658 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 180 | 272 | 522 | 535 | 402 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 198 | 354 | 607 | 608 | 408 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 236 | 782 | 1,167 | 2,020 | 2,250 |
| Total Liabilities & Shareholders' Equity | 435 | 1,136 | 1,774 | 2,628 | 2,658 |
| Total Common Shares Outstanding |